These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
359 related items for PubMed ID: 10048010
1. [Diffuse malignant melanoma of the uvea. A clinico-histopathologic study of 39 patients]. Braun UC, Rummelt VC, Naumann GO. Klin Monbl Augenheilkd; 1998 Dec; 213(6):331-40. PubMed ID: 10048010 [Abstract] [Full Text] [Related]
2. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas. Isager P, Ehlers N, Overgaard J. Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846 [Abstract] [Full Text] [Related]
9. [The staging of malignant uveal melanoma]. Cernea P, Ispas G, Mihai I. Oftalmologia; 1992 Apr; 36(3):229-38. PubMed ID: 1520679 [Abstract] [Full Text] [Related]
10. [Prognostic study of malignant melanoma of the uvea treated by enucleation]. Bacin F, Kantelip B, Albuisson E, Bonhomme R. J Fr Ophtalmol; 1988 Apr; 11(10):639-49. PubMed ID: 3072363 [Abstract] [Full Text] [Related]
11. Optic nerve invasion of uveal melanoma: clinical characteristics and metastatic pattern. Lindegaard J, Isager P, Prause JU, Heegaard S. Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3268-75. PubMed ID: 16877391 [Abstract] [Full Text] [Related]
12. Cytogenetics of uveal melanoma: a 7-year clinical experience. Damato B, Duke C, Coupland SE, Hiscott P, Smith PA, Campbell I, Douglas A, Howard P. Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643 [Abstract] [Full Text] [Related]
13. Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance. Kivelä T, Eskelin S, Mäkitie T, Summanen P. Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2085-93. PubMed ID: 11481276 [Abstract] [Full Text] [Related]
14. Intraocular lymphangiogenesis in malignant melanomas of the ciliary body with extraocular extension. Heindl LM, Hofmann TN, Knorr HL, Rummelt C, Schrödl F, Schlötzer-Schrehardt U, Holbach LM, Naumann GO, Kruse FE, Cursiefen C. Invest Ophthalmol Vis Sci; 2009 May; 50(5):1988-95. PubMed ID: 19151383 [Abstract] [Full Text] [Related]
15. The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma. Mudhar HS, Saunders E, Rundle P, Rennie IG, Sisley K. Br J Ophthalmol; 2009 Apr; 93(4):535-40. PubMed ID: 19019926 [Abstract] [Full Text] [Related]
16. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population. Bergman L, Nilsson B, Lundell G, Lundell M, Seregard S. Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063 [Abstract] [Full Text] [Related]
17. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Rouberol F, Roy P, Kodjikian L, Gérard JP, Jean-Louis B, Grange JD. Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155 [Abstract] [Full Text] [Related]
18. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy. Summanen P, Immonen I, Heikkonen J, Tommila P, Laatikainen L, Tarkkanen A. Ophthalmic Surg; 1993 Feb; 24(2):82-90. PubMed ID: 8446359 [Abstract] [Full Text] [Related]
19. Local environmental influences on uveal melanoma: vitreous humor promotes uveal melanoma invasion, whereas the aqueous can be inhibitory. Canovas D, Rennie IG, Nichols CE, Sisley K. Cancer; 2008 Apr 15; 112(8):1787-94. PubMed ID: 18300240 [Abstract] [Full Text] [Related]
20. Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma. Schmittel A, Bechrakis NE, Martus P, Mutlu D, Scheibenbogen C, Bornfeld N, Foerster MH, Thiel E, Keilholz U. Eur J Cancer; 2004 Nov 15; 40(16):2389-95. PubMed ID: 15519510 [Abstract] [Full Text] [Related] Page: [Next] [New Search]